BR0213162A - Métodos para prevenção e tratamento da perda óssea com compostos esteróides - Google Patents

Métodos para prevenção e tratamento da perda óssea com compostos esteróides

Info

Publication number: BR0213162A
Authority: BR; Brazil
Prior art keywords: prevention; treatment; methods; bone loss; steroid compounds
Prior art date: 2001-10-10

Application number

BR0213162-5A

Other languages

English (en)

Portuguese (pt)

Inventor

Enrico Di Salle

Giorgio Massimini

Colin Lowery

Paul Edward Goss

Original Assignee

Pharmacia Italia Spa

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-10

Filing date

2002-09-30

Publication date

2004-09-14

2002-09-30 Application filed by Pharmacia Italia Spa, Upjohn Co filed Critical Pharmacia Italia Spa

2004-09-14 Publication of BR0213162A publication Critical patent/BR0213162A/pt

Links

206010065687 Bone loss Diseases 0.000 title abstract 2
230000002265 prevention Effects 0.000 title abstract 2
-1 steroid compounds Chemical class 0.000 title abstract 2
BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 abstract 1
230000002159 abnormal effect Effects 0.000 abstract 1
210000000988 bone and bone Anatomy 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229960000255 exemestane Drugs 0.000 abstract 1
208000030159 metabolic disease Diseases 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Health & Medical Sciences (AREA)
Physical Education & Sports Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BR0213162-5A 2001-10-10 2002-09-30 Métodos para prevenção e tratamento da perda óssea com compostos esteróides BR0213162A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US32820901P	2001-10-10	2001-10-10
PCT/EP2002/011123 WO2003032961A2 (en)	2001-10-10	2002-09-30	Methods for preventing and treating bone loss with steroid compounds

Publications (1)

Publication Number	Publication Date
BR0213162A true BR0213162A (pt)	2004-09-14

Family

ID=23279989

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR0213162-5A BR0213162A (pt)	2001-10-10	2002-09-30	Métodos para prevenção e tratamento da perda óssea com compostos esteróides

Country Status (12)

Country	Link
EP (1)	EP1435967A2 (de)
JP (1)	JP2005508958A (de)
KR (1)	KR20050032507A (de)
CN (1)	CN1713915A (de)
BR (1)	BR0213162A (de)
CA (1)	CA2463142A1 (de)
IL (1)	IL161162A0 (de)
MX (1)	MXPA04003405A (de)
NZ (1)	NZ532064A (de)
PL (1)	PL370080A1 (de)
WO (1)	WO2003032961A2 (de)
ZA (1)	ZA200402734B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040053900A1 (en) *	1998-12-23	2004-03-18	Pharmacia Corporation	Method of using a COX-2 inhibitor and an aromatase inhibitor as a combination therapy
WO2005027916A1 (en) *	2003-09-19	2005-03-31	Pfizer Products Inc.	Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
US7332482B2 (en)	2003-09-24	2008-02-19	Bioxell S.P.A.	Method for treating benign prostatic hyperplasia
EP1937251A2 (de) *	2005-04-25	2008-07-02	Pfizer Products Inc.	Pharmazeutische zusammensetzungen und verfahren mit einer kombination aus einem selektiven östrogen-rezeptor-modulator und einem aromatasehemmer
RS56042B1 (sr)	2010-06-10	2017-09-29	Seragon Pharmaceuticals Inc	Modulatori estrogenih receptora i njihove upotrebe
WO2013090829A1 (en)	2011-12-14	2013-06-20	Aragon Pharmaceuticals, Inc.	Estrogen receptor modulators and uses thereof
SI3050878T1 (sl)	2013-09-24	2022-01-31	Fujifilm Corporation	Nova dušik-vsebujoča spojina ali njena sol ali kovinski kompleks le-te
SG11201805387RA (en)	2015-12-30	2018-07-30	Univ Saint Louis	Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8721384D0 (en) *	1987-09-11	1987-10-21	Erba Farmitalia	17-substituted andro-sta-1 4-dien-3-one derivatives
GB2294879A (en) *	1994-10-19	1996-05-15	Merck & Co Inc	Cylcooxygenase-2 Inhibitors
US6590079B2 (en) *	1997-01-30	2003-07-08	Ixsys, Incorporated	Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same
ID28460A (id) *	1998-07-08	2001-05-24	Lipogenics Inc	Komposisi dan metoda untuk perlakuan dan pencegahan penyakit tulang dengan menggunakan tocotrienol
WO2001012206A2 (de) *	1999-08-13	2001-02-22	Heinrich Wieland	Soja-glycine extracten und aromatase-hemendern zur positiven beeinflussung von kollagen

2002
- 2002-09-30 EP EP02801313A patent/EP1435967A2/de not_active Withdrawn
- 2002-09-30 CA CA002463142A patent/CA2463142A1/en not_active Abandoned
- 2002-09-30 KR KR1020047005231A patent/KR20050032507A/ko not_active Ceased
- 2002-09-30 JP JP2003535765A patent/JP2005508958A/ja active Pending
- 2002-09-30 NZ NZ532064A patent/NZ532064A/en unknown
- 2002-09-30 CN CNA028201167A patent/CN1713915A/zh active Pending
- 2002-09-30 WO PCT/EP2002/011123 patent/WO2003032961A2/en not_active Ceased
- 2002-09-30 BR BR0213162-5A patent/BR0213162A/pt not_active IP Right Cessation
- 2002-09-30 MX MXPA04003405A patent/MXPA04003405A/es unknown
- 2002-09-30 IL IL16116202A patent/IL161162A0/xx unknown
- 2002-09-30 PL PL02370080A patent/PL370080A1/xx not_active Application Discontinuation
2004
- 2004-04-07 ZA ZA200402734A patent/ZA200402734B/en unknown

Also Published As

Publication number	Publication date
WO2003032961A3 (en)	2003-09-04
IL161162A0 (en)	2004-08-31
EP1435967A2 (de)	2004-07-14
ZA200402734B (en)	2005-01-13
CN1713915A (zh)	2005-12-28
CA2463142A1 (en)	2003-04-24
PL370080A1 (en)	2005-05-16
MXPA04003405A (es)	2004-06-18
WO2003032961A2 (en)	2003-04-24
KR20050032507A (ko)	2005-04-07
NZ532064A (en)	2006-04-28
JP2005508958A (ja)	2005-04-07

Similar Documents

Publication	Publication Date	Title
BR9813524A (pt)	2002-02-19	Processos para tratamento de toxicidades associadas com a administração de um agente terapêutico a um mamìfero, para tratamento de toxicidades associadas com a exposição de um mamìfero à terapia de radiação, para tratamento de neuro- ou nefrodistúrbios em um humano, e, para tratamento de distúrbios e sintomas clìnicos associados com diabetes do tipo i ou do tipo ii em um humano
BR0013122A (pt)	2002-04-30	Ciclobenzaprina para tratamento de distúrbio de ansiedade generalizado e composições de ciclobenzaprina
BR0211364A (pt)	2004-07-13	Composição farmacêutica para tratamento de doenças associadas com redução na massa óssea compreendendo o agonista ep4 como componente ativo
BR0009647A (pt)	2002-01-08	Docetaxel em combinação com rhumab her2 para o tratamento de cânceres
BR0206639A (pt)	2004-02-25	Combinações de inibidor(es) da absorção do esterol com modificador(es) do sangue para o tratamento de condições vasculares
BR0318269A (pt)	2006-05-23	composições, alvos, métodos e dispositivos para a terapia de distúrbios oculares e perioculares
BR0211062A (pt)	2004-07-20	Combinações para o tratamento de distúrbios inflamatórios
BR9712824A (pt)	1999-12-21	Composição oftálmica de fator neurotrófico, agente de tratamento de desordem funcional do nervo ótico e método para tratamento de desordem funcional do nervo ótico
BR9812134A (pt)	2000-07-18	Composição farmacêutica para tratamento de dismenorréia e parto prematuro
BR0309623A (pt)	2005-02-09	Agentes que regulam. inibem ou modulam a atividade e/ou a expressão do fator de crescimento de tecido conjuntivo (ctgf) como um único meio de diminuir a pressão intraocular e tratar retinopatias glaucomatosas/neuropatias ópticas
BR0317747A (pt)	2005-11-22	Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave
GB0108592D0 (en)	2001-05-23	Therapeutic agents
BR0015974A (pt)	2002-07-23	Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto
BR0113447A (pt)	2003-07-08	Método de tratamento ou prevenção do câncer em um ser humano, e, composição farmacêutica
BR9814923A (pt)	2000-10-17	Método para tratamento de doença de alzheimer
BRPI0512220A (pt)	2008-02-19	método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto
BRPI0512213A (pt)	2008-02-19	método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto
BRPI0411295A (pt)	2006-08-01	compostos e seu uso na terapia
PL1703902T3 (pl)	2011-04-29	Memantyna do leczenia choroby Alzheimera o łagodnym do umiarkowanego stopniu zaawansowania
BR0014312A (pt)	2002-05-21	Combinação de loteprednol e anti-histaminas
BR0315573A (pt)	2005-08-30	Método para tratar, prevenir, controlar e/ou modificar dor em um paciente e composição farmacêutica
BRPI0408491A (pt)	2006-04-04	tratamento da doença de alzheimer
BR0200246A (pt)	2002-10-29	Tratamento de combinação para a depressão
BR0213162A (pt)	2004-09-14	Métodos para prevenção e tratamento da perda óssea com compostos esteróides
BR9812660A (pt)	2000-08-22	Composições e métodos para tratar distúrbios respiratórios

Legal Events

Date	Code	Title	Description
2010-06-29	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 6A,7A E 8A ANUIDADES
2011-07-19	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010.